Pub Date : 2023-05-13DOI: 10.47316/cajmhe.2023.4.1.01
Erhan Kaya, Musa Şahin, Yavuzalp Solak, O. Acar, Celal Kuş, M. Kuş, Muhammed Mustafa Beyoğlu, B. Koçyiğit
The proceeding 2022 multicountry epidemic of Monkeypox emerges as a global health concern. The first death outside of Africa appeared in Brazil on July 29, 2022, and the first death in Europe occurred in Spain on July 29, 2022. As a result, the World Health Organization announced the monkeypox epidemic as a global public health emergency on July 2022. Therefore, we aimed to present a review in light of contemporary facts. We conducted a review of current details on Monkeypox. Close contact is the best-known risk factor for human-to-human transmission; a pregnant woman can pass the virus to the fetus. The approximative incubation period is 10-14 days. Prodromal symptoms are fever, malaise, chills, and lymphadenopathy. Then clinicians observe that rash develops in most patients. Monkeypox usually takes 2-4 weeks on its own. The plurality of monkeypox patients recovers without treatment. However, some patients with complications may need treatment. Children, pregnant women, and immunocompromised individuals may develop a longer disease because of eye infections, pneumonia, and encephalitis. Physicians use anamnesis, clinical signs, and laboratory tests to diagnose infection. Infected animals and patients should be quarantined. There is no specific vaccine still. Nevertheless, the smallpox vaccine protects 85% against monkeypox, according to early reports. Antiviral drugs, Tecovirimat, Cidofovir, Brincidofovir, and Human Vaccinia Immune Globulin, can potentially treat. Our review centers on clinical knowledge for the efficacious management, prevention, and guidance of monkeypox responders and patients globally.
{"title":"AN OVERVIEW OF MONKEYPOX OUTBREAK","authors":"Erhan Kaya, Musa Şahin, Yavuzalp Solak, O. Acar, Celal Kuş, M. Kuş, Muhammed Mustafa Beyoğlu, B. Koçyiğit","doi":"10.47316/cajmhe.2023.4.1.01","DOIUrl":"https://doi.org/10.47316/cajmhe.2023.4.1.01","url":null,"abstract":"The proceeding 2022 multicountry epidemic of Monkeypox emerges as a global health concern. The first death outside of Africa appeared in Brazil on July 29, 2022, and the first death in Europe occurred in Spain on July 29, 2022. As a result, the World Health Organization announced the monkeypox epidemic as a global public health emergency on July 2022. Therefore, we aimed to present a review in light of contemporary facts. We conducted a review of current details on Monkeypox. Close contact is the best-known risk factor for human-to-human transmission; a pregnant woman can pass the virus to the fetus. The approximative incubation period is 10-14 days. Prodromal symptoms are fever, malaise, chills, and lymphadenopathy. Then clinicians observe that rash develops in most patients. Monkeypox usually takes 2-4 weeks on its own. The plurality of monkeypox patients recovers without treatment. However, some patients with complications may need treatment. Children, pregnant women, and immunocompromised individuals may develop a longer disease because of eye infections, pneumonia, and encephalitis. Physicians use anamnesis, clinical signs, and laboratory tests to diagnose infection. Infected animals and patients should be quarantined. There is no specific vaccine still. Nevertheless, the smallpox vaccine protects 85% against monkeypox, according to early reports. Antiviral drugs, Tecovirimat, Cidofovir, Brincidofovir, and Human Vaccinia Immune Globulin, can potentially treat. Our review centers on clinical knowledge for the efficacious management, prevention, and guidance of monkeypox responders and patients globally.","PeriodicalId":388483,"journal":{"name":"Central Asian Journal of Medical Hypotheses and Ethics","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116123516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-13DOI: 10.47316/cajmhe.2023.4.1.04
J. A. Teixeira da Silva, G. Kendall
Academics (should) strive to submit to journals which are academically sound and scholarly. To achieve this, they could either submit to journals that appear exclusively on safelists (occasionally referred to as whitelists, although this term tends to be avoided), or avoid submitting to journals on watchlists (occasionally referred to as blacklists, although this term tends to be avoided). The most well-known of these lists was curated by Jeffrey Beall. Beall’s Lists (there are two, one for stand-alone journals and one for publishers) were taken offline by Beall himself in January 2017. Prior to 2017, Beall’s Lists were widely cited and utilized, including to make quantitative claims about scholarly publishing. Even after Beall’s Lists became obsolete (they have not been maintained for the past six years), they continue to be widely cited and used. This paper argues that the use of Beall’s Lists, pre- and post-2017, may constitute a methodological error and, even if papers carry a disclaimer or limitations section noting this weakness, their conclusions cannot always be relied upon. This paper also argues for the need to conduct a detailed post-publication assessment of reports in the literature that used Beall’s Lists to validate their findings and conclusions, assuming that it becomes accepted that Beall’s Lists are not a reliable resource for scientific investigation. Finally, this paper contends that any papers that have identified methodological errors should be corrected. Several lists that were cloned from Beall’s Lists have also emerged and are also being cited. These should also be included in any post-publication investigation that is conducted.
{"title":"ACADEMIA SHOULD STOP USING BEALL’S LISTS AND REVIEW THEIR USE IN PREVIOUS STUDIES","authors":"J. A. Teixeira da Silva, G. Kendall","doi":"10.47316/cajmhe.2023.4.1.04","DOIUrl":"https://doi.org/10.47316/cajmhe.2023.4.1.04","url":null,"abstract":"Academics (should) strive to submit to journals which are academically sound and scholarly. To achieve this, they could either submit to journals that appear exclusively on safelists (occasionally referred to as whitelists, although this term tends to be avoided), or avoid submitting to journals on watchlists (occasionally referred to as blacklists, although this term tends to be avoided). The most well-known of these lists was curated by Jeffrey Beall. Beall’s Lists (there are two, one for stand-alone journals and one for publishers) were taken offline by Beall himself in January 2017. Prior to 2017, Beall’s Lists were widely cited and utilized, including to make quantitative claims about scholarly publishing. Even after Beall’s Lists became obsolete (they have not been maintained for the past six years), they continue to be widely cited and used. This paper argues that the use of Beall’s Lists, pre- and post-2017, may constitute a methodological error and, even if papers carry a disclaimer or limitations section noting this weakness, their conclusions cannot always be relied upon. This paper also argues for the need to conduct a detailed post-publication assessment of reports in the literature that used Beall’s Lists to validate their findings and conclusions, assuming that it becomes accepted that Beall’s Lists are not a reliable resource for scientific investigation. Finally, this paper contends that any papers that have identified methodological errors should be corrected. Several lists that were cloned from Beall’s Lists have also emerged and are also being cited. These should also be included in any post-publication investigation that is conducted.","PeriodicalId":388483,"journal":{"name":"Central Asian Journal of Medical Hypotheses and Ethics","volume":"66 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127454999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-13DOI: 10.47316/cajmhe.2023.4.1.06
I. Benlidayı
POST-PUBLICATION REVIEW
出版审查
{"title":"POST-PUBLICATION REVIEW","authors":"I. Benlidayı","doi":"10.47316/cajmhe.2023.4.1.06","DOIUrl":"https://doi.org/10.47316/cajmhe.2023.4.1.06","url":null,"abstract":"POST-PUBLICATION REVIEW","PeriodicalId":388483,"journal":{"name":"Central Asian Journal of Medical Hypotheses and Ethics","volume":"104 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115670805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-30DOI: 10.47316/cajmhe.2022.3.4.05
S. Santhanam, M. Goyal
Scientific knowledge needs to be widely disseminated across the globe, for it to be critically analyzed or to be built upon for future studies. The conventional publication model has been less accessible due to prohibitive subscription costs and hence the need arose for the open access model where the readers would have free access. The Open Science movement is not only about open-access journals but also includes open source, open data and methodology, open peer review, open-access indexing, and archiving. The prototype open access model is the gold model where researchers (themselves or supported by grants or funding agencies) pay certain article processing charges and the readers have free access to the content without any restrictions. Additionally, there is a need for free-to-use open-access platforms or repositories like PubMed Central to archive the open-access content. Institutional repository is another way for collecting, archiving, and distributing the scholarly contents of an academic institution. Preprint servers allow archiving manuscripts before they are submitted to or undergo review for publication, and they offer an important platform for freely sharing knowledge. While open-access model looks attractive, it has its challenges. Currently, the change to open-access model has meant the transfer of the financial burden, earlier borne by the readers, to the authors in the form of APCs. Irrespective of the model, there is a need to reconsider the high subscription costs and the article processing charges which are often prohibitive for many. Science must be accessible to the researchers and the public at a reasonable cost without delay.
{"title":"OPEN ACCESS PUBLISHING — “SO NEAR AND YET SO FAR”","authors":"S. Santhanam, M. Goyal","doi":"10.47316/cajmhe.2022.3.4.05","DOIUrl":"https://doi.org/10.47316/cajmhe.2022.3.4.05","url":null,"abstract":"Scientific knowledge needs to be widely disseminated across the globe, for it to be critically analyzed or to be built upon for future studies. The conventional publication model has been less accessible due to prohibitive subscription costs and hence the need arose for the open access model where the readers would have free access. The Open Science movement is not only about open-access journals but also includes open source, open data and methodology, open peer review, open-access indexing, and archiving. The prototype open access model is the gold model where researchers (themselves or supported by grants or funding agencies) pay certain article processing charges and the readers have free access to the content without any restrictions. Additionally, there is a need for free-to-use open-access platforms or repositories like PubMed Central to archive the open-access content. Institutional repository is another way for collecting, archiving, and distributing the scholarly contents of an academic institution. Preprint servers allow archiving manuscripts before they are submitted to or undergo review for publication, and they offer an important platform for freely sharing knowledge. While open-access model looks attractive, it has its challenges. Currently, the change to open-access model has meant the transfer of the financial burden, earlier borne by the readers, to the authors in the form of APCs. Irrespective of the model, there is a need to reconsider the high subscription costs and the article processing charges which are often prohibitive for many. Science must be accessible to the researchers and the public at a reasonable cost without delay.","PeriodicalId":388483,"journal":{"name":"Central Asian Journal of Medical Hypotheses and Ethics","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133209809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-30DOI: 10.47316/cajmhe.2022.3.4.06
J. A. Teixeira da Silva
DYSTOPIAN CASES OF ORCID IDENTIFIERS: ANIMAL-ASSOCIATED ACCOUNTS
orcid标识符的反乌托邦案例:与动物相关的账户
{"title":"DYSTOPIAN CASES OF ORCID IDENTIFIERS: ANIMAL-ASSOCIATED ACCOUNTS","authors":"J. A. Teixeira da Silva","doi":"10.47316/cajmhe.2022.3.4.06","DOIUrl":"https://doi.org/10.47316/cajmhe.2022.3.4.06","url":null,"abstract":"DYSTOPIAN CASES OF ORCID IDENTIFIERS: ANIMAL-ASSOCIATED ACCOUNTS","PeriodicalId":388483,"journal":{"name":"Central Asian Journal of Medical Hypotheses and Ethics","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121547331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-30DOI: 10.47316/cajmhe.2022.3.4.08
W. Grant
MY LIFE AS A VITAMIN D RESEARCHER
我作为维生素d研究人员的生活
{"title":"MY LIFE AS A VITAMIN D RESEARCHER","authors":"W. Grant","doi":"10.47316/cajmhe.2022.3.4.08","DOIUrl":"https://doi.org/10.47316/cajmhe.2022.3.4.08","url":null,"abstract":"MY LIFE AS A VITAMIN D RESEARCHER","PeriodicalId":388483,"journal":{"name":"Central Asian Journal of Medical Hypotheses and Ethics","volume":"419 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122102509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-30DOI: 10.47316/cajmhe.2022.3.4.01
G. Iliopoulos, D. Daoussis
ACTH is a pituitary hormone important for proper function of adrenal glands, cortisol production as well as human physiology in general. It is involved in the pathogenesis of several endocrine disorders like Cushing syndrome and can be a useful diagnostic tool for diseases like primary adrenal insufficiency. Although popular as a hormone in endocrine system physiology and testing, ACTH has been used as a drug since the 1950s. Except for steroid-releasing properties, its mechanism of action involves a steroid-independent anti-inflammatory and possible immune-modulatory effect. Pharmaceutic ACTH has a wide range of indications approved by FDA and usually comes in the form of subcutaneous injections. In this narrative review, we accumulated what we considered as important data from reviews, cases and trials involving the most basic FDA-approved ACTH indications. A special emphasis was given on rheumatologic indications of ACTH. More large data studies need to be performed to assess ACTH usefulness, efficacy, safety and cost-effectiveness as a drug.
{"title":"FDA-APPROVED INDICATIONS OF ADRENOCORTICOTROPIC HORMONE (ACTH) AS A DRUG: DOES IT HAVE A PLACE IN DISEASE MANAGEMENT TODAY?","authors":"G. Iliopoulos, D. Daoussis","doi":"10.47316/cajmhe.2022.3.4.01","DOIUrl":"https://doi.org/10.47316/cajmhe.2022.3.4.01","url":null,"abstract":"ACTH is a pituitary hormone important for proper function of adrenal glands, cortisol production as well as human physiology in general. It is involved in the pathogenesis of several endocrine disorders like Cushing syndrome and can be a useful diagnostic tool for diseases like primary adrenal insufficiency. Although popular as a hormone in endocrine system physiology and testing, ACTH has been used as a drug since the 1950s. Except for steroid-releasing properties, its mechanism of action involves a steroid-independent anti-inflammatory and possible immune-modulatory effect. Pharmaceutic ACTH has a wide range of indications approved by FDA and usually comes in the form of subcutaneous injections. In this narrative review, we accumulated what we considered as important data from reviews, cases and trials involving the most basic FDA-approved ACTH indications. A special emphasis was given on rheumatologic indications of ACTH. More large data studies need to be performed to assess ACTH usefulness, efficacy, safety and cost-effectiveness as a drug. ","PeriodicalId":388483,"journal":{"name":"Central Asian Journal of Medical Hypotheses and Ethics","volume":"2014 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128650023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-30DOI: 10.47316/cajmhe.2022.3.4.03
M. Tezcan, S. A. Kasman
Typical interstitial pneumonia (IP) is mainly the fibrotic form of interstitial lung disease. In some cases with typical IP, a certain amount of ground-glass opacity (GGO) can be detected on high-resolution computed tomography, however, some important issues, such as the co-existence of GGO and typical IP, still require further investigation by biopsy. After the diagnosis of typical IP, anti-fibrosis treatment is usually considered. Here, we hypothesized that GGO in typical IP could be a manifestation of an acute inflammatory attack requiring immunosuppressive therapy or an indicator of ongoing contact with trigger factors that initiate pathological reactions in typical IP.
{"title":"GROUND GLASS OPACITIES: SIGN OF CAUTION IN TYPICAL INTERSTITIAL PNEUMONIA","authors":"M. Tezcan, S. A. Kasman","doi":"10.47316/cajmhe.2022.3.4.03","DOIUrl":"https://doi.org/10.47316/cajmhe.2022.3.4.03","url":null,"abstract":"Typical interstitial pneumonia (IP) is mainly the fibrotic form of interstitial lung disease. In some cases with typical IP, a certain amount of ground-glass opacity (GGO) can be detected on high-resolution computed tomography, however, some important issues, such as the co-existence of GGO and typical IP, still require further investigation by biopsy. After the diagnosis of typical IP, anti-fibrosis treatment is usually considered. Here, we hypothesized that GGO in typical IP could be a manifestation of an acute inflammatory attack requiring immunosuppressive therapy or an indicator of ongoing contact with trigger factors that initiate pathological reactions in typical IP.","PeriodicalId":388483,"journal":{"name":"Central Asian Journal of Medical Hypotheses and Ethics","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117043622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-30DOI: 10.47316/cajmhe.2022.3.4.07
C. Gialouri, G. Fragoulis
Day by day, social media are entering our lives changing our every-day life and habits. This could not leave science unaffected. Over the last years, a lot of scientists have started using social media, exchanging ideas and sharing knowledge. Scientific journals have also followed being active participators in the social media world. In this opinion article we provide some arguments about the positive role of social media in the life of a scientist, highlighting at the same time the caveats that are encountered.
{"title":"SOCIAL MEDIA IN SCIENCE","authors":"C. Gialouri, G. Fragoulis","doi":"10.47316/cajmhe.2022.3.4.07","DOIUrl":"https://doi.org/10.47316/cajmhe.2022.3.4.07","url":null,"abstract":"Day by day, social media are entering our lives changing our every-day life and habits. This could not leave science unaffected. Over the last years, a lot of scientists have started using social media, exchanging ideas and sharing knowledge. Scientific journals have also followed being active participators in the social media world. In this opinion article we provide some arguments about the positive role of social media in the life of a scientist, highlighting at the same time the caveats that are encountered. ","PeriodicalId":388483,"journal":{"name":"Central Asian Journal of Medical Hypotheses and Ethics","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129477868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-30DOI: 10.47316/cajmhe.2022.3.4.04
Joseph A. Dorri, Leonard A. Jason
An exploratory factor analysis (EFA) can provide a window into the latent dimensions of a disease, such as Long COVID. Discovering the latent factors of Long COVID enables researchers and clinicians to better conceptualize, study and treat this disease. In this study, participants were recruited from social media sites dedicated to COVID and Long COVID. Among the 480 participants, those who completed at least 90% of the survey, reported symptoms for two or more months since COVID-19 symptom onset, and had not been hospitalized for COVID were used in the EFA. The mean duration since initial symptom onset was 74.0 (37.3) weeks. A new questionnaire called The DePaul Symptom Questionnaire-COVID was used to assess self-reports of the frequency and severity of 38 Long COVID symptoms experienced over the most recent month. The most burdensome symptoms were “Symptoms that get worse after physical or mental activities (also known as Post-Exertional Malaise),” “Fatigue/extreme tiredness,” “Difficulty thinking and/or concentrating,” “Sleep problems,” and “Muscle aches.” The EFA resulted in a three-factor model with factors labeled General, PEM/Fatigue/Cognitive Dysfunction, and Psychological, consisting of 16, 6, and 3 items respectively (25 items in total). The reliability of the items in the EFA was .90 using a split-half reliability test. Finally, participant self-reported level of functional impairment was analyzed across the three EFA factors. Interpretations and applications to research and practice are provided.
{"title":"AN EXPLORATORY FACTOR ANALYSIS OF LONG COVID","authors":"Joseph A. Dorri, Leonard A. Jason","doi":"10.47316/cajmhe.2022.3.4.04","DOIUrl":"https://doi.org/10.47316/cajmhe.2022.3.4.04","url":null,"abstract":"An exploratory factor analysis (EFA) can provide a window into the latent dimensions of a disease, such as Long COVID. Discovering the latent factors of Long COVID enables researchers and clinicians to better conceptualize, study and treat this disease. In this study, participants were recruited from social media sites dedicated to COVID and Long COVID. Among the 480 participants, those who completed at least 90% of the survey, reported symptoms for two or more months since COVID-19 symptom onset, and had not been hospitalized for COVID were used in the EFA. The mean duration since initial symptom onset was 74.0 (37.3) weeks. A new questionnaire called The DePaul Symptom Questionnaire-COVID was used to assess self-reports of the frequency and severity of 38 Long COVID symptoms experienced over the most recent month. The most burdensome symptoms were “Symptoms that get worse after physical or mental activities (also known as Post-Exertional Malaise),” “Fatigue/extreme tiredness,” “Difficulty thinking and/or concentrating,” “Sleep problems,” and “Muscle aches.” The EFA resulted in a three-factor model with factors labeled General, PEM/Fatigue/Cognitive Dysfunction, and Psychological, consisting of 16, 6, and 3 items respectively (25 items in total). The reliability of the items in the EFA was .90 using a split-half reliability test. Finally, participant self-reported level of functional impairment was analyzed across the three EFA factors. Interpretations and applications to research and practice are provided.","PeriodicalId":388483,"journal":{"name":"Central Asian Journal of Medical Hypotheses and Ethics","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132874202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：